B. J. Medical College is a medical college located in Pune, Maharashtra, India. The college, administered by the Government of Maharashtra, comprises clinical and para/pre-clinical departments working alongside the Sassoon General Hospital. Founded by Byramjee Jeejeebhoy in 1878.

During the past decade, Byramjee Jeejeebhoy Medical College (BJMC) CRS conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Byramjee Jeejeebhoy Medical College (BJMC) CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials, followed by "Allergan" with 4 trials sponsored, "AIDS Clinical Trials Group" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Galapagos NV" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Byramjee Jeejeebhoy Medical College (BJMC) CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials as a collaborator and "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Byramjee Jeejeebhoy Medical College (BJMC) CRS" are "HIV Infections" (11 trials), "Tuberculosis" (6 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Byramjee Jeejeebhoy Medical College (BJMC) CRS" in a lesser frequency.

Most popular intervention types in "Byramjee Jeejeebhoy Medical College (BJMC) CRS" are "Drug" (20 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Relamorelin" (3 trials), "Filgotinib" (2 trials), "Isoniazid (INH)" (2 trials) and "Nintedanib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Byramjee Jeejeebhoy Medical College (BJMC) CRS" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Byramjee Jeejeebhoy Medical College (BJMC) CRS". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Byramjee Jeejeebhoy Medical College (BJMC) CRS, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Byramjee Jeejeebhoy Medical College (BJMC) CRS, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".